MitraClip EXPAND G4 Study

NCT04177394 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1164

Last updated 2025-07-11

Study results available
· View outcomes & findings →

Summary

This primary objective of the EXPAND G4 study is to confirm the safety and performance of the MitraClip G4 System in a post-market setting.

Conditions

  • Mitral Valve Regurgitation
  • Mitral Regurgitation

Interventions

DEVICE

MitraClip G4 System

Percutaneous mitral valve repair using the MitraClip G4 system.

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY
  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Kartik Sundareswaran, PhD · Abbott Structural Heart

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-17
Primary Completion
2022-05-19
Completion
2028-03-31
FDA Device
Yes

Countries

  • United States
  • Canada
  • France
  • Germany
  • Israel
  • Italy
  • Japan
  • Netherlands
  • Saudi Arabia
  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04177394 on ClinicalTrials.gov